GNPTAB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.299010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.390000E-02
Normal-vs-Stage2
1.656410E-01
Normal-vs-Stage3
5.587500E-02
Normal-vs-Stage4
7.878400E-01
Stage1-vs-Stage2
3.952600E-01
Stage1-vs-Stage3
7.066800E-01
Stage1-vs-Stage4
1.395820E-01
Stage2-vs-Stage3
3.173800E-01
Stage2-vs-Stage4
2.556200E-01
Stage3-vs-Stage4
1.463010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.223790E-01
Normal-vs-AfricanAmerican
3.470200E-01
Normal-vs-Asian
7.819900E-02
Caucasian-vs-AfricanAmerican
6.762000E-01
Caucasian-vs-Asian
1.756020E-01
AfricanAmerican-vs-Asian
2.913600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.399220E-01
Normal-vs-Female
1.289360E-01
Male-vs-Female
6.313000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.168630E-01
Normal-vs-Age(41-60Yrs)
2.379200E-01
Normal-vs-Age(61-80Yrs)
1.148040E-01
Normal-vs-Age(81-100Yrs)
7.556400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.378200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.477200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.929400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.307600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.288170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.970200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.119900E-02
Normal-vs-Daily Drinker
5.087900E-02
Normal-vs-Weekly Drinker
1.491240E-01
Normal-vs-Occasional Drinker
1.789230E-01
Normal-vs-Social Drinker
3.317400E-01
Non Drinker-vs-Daily Drinker
8.953800E-01
Non Drinker-vs-Weekly Drinker
2.309600E-01
Non Drinker-vs-Occasional Drinker
1.035400E-01
Non Drinker-vs-Social Drinker
1.017000E-01
Daily Drinker-vs-Weekly Drinker
2.693200E-01
Daily Drinker-vs-Occasional Drinker
1.390370E-01
Daily Drinker-vs-Social Drinker
1.402610E-01
Weekly Drinker-vs-Occasional Drinker
7.840200E-01
Weekly Drinker-vs-Social Drinker
6.716000E-01
Occasional Drinker-vs-Social Drinker
8.321800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.878200E-01
Normal-vs-Grade 2
4.682100E-02
Normal-vs-Grade 3
8.570500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.544100E-02
Grade 1-vs-Grade 3
8.978000E-02
Grade 1-vs-Grade 4
1.878200E-01
Grade 2-vs-Grade 3
6.178000E-01
Grade 2-vs-Grade 4
4.682100E-02
Grade 3-vs-Grade 4
8.570500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.306210E-01
Normal-vs-NonDiabetic
5.671900E-02
Diabetic-vs-NonDiabetic
5.871200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.881900E-02
Normal-vs-NoPancreatitis
9.240500E-02
Pancreatitis-vs-NoPancreatitis
5.661800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.640400E-02
Normal-vs-N1
1.661990E-01
N0-vs-N1
2.947800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.799810E-01
Normal-vs-TP53-NonMutant
1.270980E-01
TP53-Mutant-vs-TP53-NonMutant
7.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
